The COVID-19 pandemic caused rapid growth in Indonesia's pharmaceutical and medicinal drug industry.
A similar trend occurred globally. According to a *Nature Reviews Drug Discovery* report released in March 2022, multinational pharmaceutical companies recorded significant growth in global drug sales during the pandemic.
Here are the top 5 best-selling drugs globally in 2021:
1. Comirnaty (Pfizer): US$36.9 billion (Rp531.22 trillion)
2. Humira (AbbVie): US$20.7 billion (Rp298 trillion)
3. Spikevax (Moderna): US$17.7 billion (Rp254.8 trillion)
4. Keytruda (Merck & Co.): US$17.2 billion (Rp247.6 trillion)
5. Revlimid (Bristol Myers Squibb): US$12.8 billion (Rp184.27 trillion)
Comirnaty, the COVID-19 vaccine produced by Pfizer, was the world's best-selling drug in 2021, with total sales reaching US$36.9 billion.
The next highest-selling drug globally was Humira, produced by AbbVie. This drug is used to reduce symptoms and prevent rheumatoid arthritis or joint inflammation.
Other top-selling drugs include the COVID-19 vaccine Spikevax from Moderna, Keytruda, used as an immunotherapy drug, and Revlimid, used in bone marrow cancer therapy.
(Read Also: The Chemical, Pharmaceutical, and Traditional Medicine Industries Continue to Grow During the COVID-19 Pandemic)